| Margaret Danielle Mullins-moats, FNP-C | |
|
3812 W Main St., Russellville, AR 72801 | |
| (479) 968-1245 | |
| Not Available |
| Full Name | Margaret Danielle Mullins-moats |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3812 W Main St., Russellville, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114418993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A005654 (Arkansas) | Primary |
| Entity Name | Arkansas Emergency Physician Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720529498 PECOS PAC ID: 7911284500 Enrollment ID: O20170509001162 |
News Archive
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Sonic Innovations, Inc. received a Best in Show award based on attendees' votes at the AudiologyNOW! conference for its tradeshow booth. The conference was held April 14 through 17 in San Diego, California and was attended by nearly 7,000 hearing care professionals.
A gene essential to the production of pain-sensing neurons in humans has been identified by an international team of researchers co-led by the University of Cambridge. The discovery, reported today in the journal Nature Genetics, could have implications for the development of new methods of pain relief.
Treating sick babies with engineered breast milk could someday be a reality, according to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.
› Verified 3 days ago
| Entity Name | Westside Family Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801587779 PECOS PAC ID: 3476915372 Enrollment ID: O20230809001884 |
News Archive
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Sonic Innovations, Inc. received a Best in Show award based on attendees' votes at the AudiologyNOW! conference for its tradeshow booth. The conference was held April 14 through 17 in San Diego, California and was attended by nearly 7,000 hearing care professionals.
A gene essential to the production of pain-sensing neurons in humans has been identified by an international team of researchers co-led by the University of Cambridge. The discovery, reported today in the journal Nature Genetics, could have implications for the development of new methods of pain relief.
Treating sick babies with engineered breast milk could someday be a reality, according to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret Danielle Mullins-moats, FNP-C 3812 W Main St., Russellville, AR 72801 Ph: (479) 393-9303 | Margaret Danielle Mullins-moats, FNP-C 3812 W Main St., Russellville, AR 72801 Ph: (479) 968-1245 |
News Archive
Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Sonic Innovations, Inc. received a Best in Show award based on attendees' votes at the AudiologyNOW! conference for its tradeshow booth. The conference was held April 14 through 17 in San Diego, California and was attended by nearly 7,000 hearing care professionals.
A gene essential to the production of pain-sensing neurons in humans has been identified by an international team of researchers co-led by the University of Cambridge. The discovery, reported today in the journal Nature Genetics, could have implications for the development of new methods of pain relief.
Treating sick babies with engineered breast milk could someday be a reality, according to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.
› Verified 3 days ago
Karen Michelle Branch, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2210 W Main St, Russellville, AR 72801 Phone: 479-968-8940 Fax: 479-968-8901 | |
Ashley Mccoy, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 209 S Portland Ave, Russellville, AR 72801 Phone: 501-906-0000 | |
Mrs. Ashley Nichole Bennett, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-968-2841 | |
Kristy Hogan, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 402 W O St, Dean Hall, Room 126, Russellville, AR 72801 Phone: 479-368-0329 | |
Ms. Candace Darlene Welcher, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 101 Skyline Dr, Russellville, AR 72801 Phone: 479-968-2345 Fax: 479-890-2467 | |
Lindsey Sharp, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-964-2198 |